Alnylam Pharmaceuticals, Inc. (ALNY)

224.03 -3.25 (-1.43%) USD  |  NASDAQ  |  Oct 23, 16:00
223.90 -0.13 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Pfizer Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade